Remicade 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FV091
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,391
Award facts
- Contract value 100% obligated
- $14,391.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,391.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Remicade, with an ultimate completion date of December 31, 2025. This competitively awarded contract, issued on December 30, 2025, carries no set-aside designation and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. Remicade is a biologic immunosuppressant medication used to treat inflammatory conditions including rheumatoid arthritis, psoriasis, and inflammatory bowel disease, making it a critical pharmaceutical for military and veteran healthcare systems supported by DLA.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen maintains an extensive portfolio of federal medical supply contracts with the Defense Logistics Agency, delivering specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs globally. The firm fixed-price delivery order structure demonstrates the company's established capability to fulfill federal pharmaceutical procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26FV091?
SPE2DR26FV091 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FV091 worth?
The government has obligated $14,391 on SPE2DR26FV091.
Is contract SPE2DR26FV091 an order under another contract?
Yes. SPE2DR26FV091 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV091 competed?
The extent of competition for SPE2DR26FV091 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award